The transcatheter tricuspid valve reconstruction system performs as intended with an acceptable safety profile in patients with symptomatic and moderate-to-severe functional tricuspid regurgitation (TR), reports a recent study.
The implantable cardiac system can detect early ST-segment deviation among patients with acute coronary syndrome (ACS), as well as alert them of a possible occlusive event, according to the results of the ALERTS* trial, a multicentre, randomized trial of an implantable cardiac monitor that alerts patients with rapidly progressive ST-segment deviation.
While hypertensive patients with dizziness have no high-risk profile at baseline, those with vertigo are at an increased risk of stroke mortality and thus must be carefully monitored over years, according to a recent study.
Asian patients with heart failure appear to have a lower prevalence of atrial fibrillation (AF) compared with their New Zealand European counterparts, and diabetes is associated with lower odds of AF among Asians, as shown in a recent study.
A recent survey with patients taking chronic antithrombotic medications has shown that timeliness, accuracy and adaptiveness to prior patient experiences while offering a single, consistently available point of contact are deemed necessary to enhance the communication process in periprocedural antithrombotic medication management.
Dual-antiplatelet therapy (DAPT) may increase the risk of bleeding and ischaemic events in patients with second-generation drug-eluting stent (2nd-DES) implants undergoing haemodialysis (HD), a recent study suggests.
At a webinar hosted by Pfizer, leading Malaysian family medicine specialists Professor Chia Yook Chin andProfessor Sherina Mohd Sidik discussed a host of issues commonly encountered in primary care, includingpreventing cardiovascular (CV) disease, pain control in osteoarthritis (OA) and depression management.
Omega-3 fatty acid (FA) supplements do not yield significant cardiovascular benefits, according to a recent meta-analysis, which shows no reduction in fatal or nonfatal coronary heart disease (CHD) or major vascular events following supplementation.